BIM Deletion Polymorphism Profiling Complements Prognostic Values of Risk Scores in Imatinib-treated Asian Chronic Myeloid Leukemia Patients
10.1080/10428194.2018.1461863
Saved in:
Main Authors: | Hein Than, Weng Kit Lye, Colin Sng, John Allen, S., Tiong Ong, Charles Chuah |
---|---|
Other Authors: | DUKE-NUS MEDICAL SCHOOL |
Format: | Others |
Published: |
Taylor & Francis
2019
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/152348 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Overcoming imatinib resistance conferred by the BIM deletion polymorphism in chronic myeloid leukemia with splice-switching antisense oligonucleotides
by: Liu, Jun, et al.
Published: (2018) -
Overcoming imatinib resistance conferred by the BIM deletion polymorphism in chronic myeloid leukemia with splice-switching antisense oligonucleotides
by: Liu, J, et al.
Published: (2020) -
Profile of BCR-ABL transcript levels based on Sokal prognostic score in chronic myeloid leukemia patients treated with imatinib
by: Ami Ashariati Prayoga, et al.
Published: (2014) -
The HDAC inhibitor SB939 overcomes resistance to BCR-ABL kinase Inhibitors conferred by the BIM deletion polymorphism in chronic myeloid leukemia
by: Rauzan M., et al.
Published: (2020) -
Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia
by: Giuseppe Saglio, et al.
Published: (2018)